Investors Sue Abbott Over $1.5B Depakote Settlement Tab
Two Abbott Laboratories Inc. shareholders sued the company's board in Illinois federal court Tuesday, claiming executives negligently allowed Abbott to promote improper off-label uses for its anti-seizure medication Depakote, forcing the...To view the full article, register now.
Already a subscriber? Click here to view full article